ClinicalTrials.Veeva

Menu

Improvement of Knowledge About the Arthrogenic Muscle Inhibition in the Aftermath of Knee Trauma. (CAMIK)

T

Toulouse University Hospital

Status

Completed

Conditions

Anterior Cruciate Ligament Rupture

Treatments

Diagnostic Test: functional brain MRI

Study type

Interventional

Funder types

Other

Identifiers

NCT03950024
RC31/19/0029
2019-A00479-48 (Other Identifier)

Details and patient eligibility

About

Arthrogenic Muscle Inhibition (AMI) is one of the classic complications occurring in the aftermath of knee trauma; AMI is grossly defined as a lack of extension due to quadriceps inhibition and hamstring contracture. However, its origins remains unknown with a strong suspicion for a central brain origin. It could be the missing link explaining this lack of extension following an anterior cruciate ligament (ACL) rupture. The primary hypothesis of this study is that a difference in activation of motor brain areas exists in patients with an ACL rupture, between those with AMI or without. The second hypothesis is that this difference could be seen on brain functional MRI.

Full description

AMI leads to quadriceps atrophy, persistent knee pain, dynamic instability, and a higher rate of osteoarthritis. A recent literature review suggests that the AMI phenomenon is multifactorial, but not widely known and poorly understood. Known mechanisms include impaired motor function at rest, impaired transmission of information from joint sensory receptors, impaired excitability of the spinal reflex and impaired cortical activity. Several studies have suggested a link between ACL rupture and central nervous system reorganization. Among the neurophysiological investigations explored are the evoked somesthesic potentials, electroencephalography, and transcranial magnetic stimulation (TMS). However, these mechanisms alone do not explain the phenomenon in its entirety, suggesting that there are other mechanisms. Furthermore, no study has used functional brain MRI to assess the existence of similar changes in AMI.

This study plans to compare two groups of patients with an ACL rupture: a group with AMI, and a group without AMI. Both groups will undergo a functional brain MRI in order to analyse any modification of the sensory-motor network connectivity that could occur.

Enrollment

42 patients

Sex

Male

Ages

20 to 30 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • male patient, right-handed,
  • with a severe right knee sprain in the event of ACL rupture,
  • occurrence of trauma within 4 weeks prior to inclusion,
  • with a score of ≥ 8/10 on the Edinburgh Manual Laterality Questionnaire, -affiliated or benefiting from public health services.

Exclusion criteria

  • person presenting any of these conditions : professional player / athlete, -contraindication to the MRI examination (claustrophobic patient, patient with a metallic element),
  • patient already operated on with ligament damage to the knee other than ACL,
  • patient with iterative ACL rupture,
  • patient who has undergone contralateral ligament reconstruction,
  • patient with multi-ligamentary knee injury,
  • patient refusing to be informed of any abnormality detected on brain MRI, -protected patient (adults under guardianship or other legal protection, deprived of their liberty by judicial or administrative decision).

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

42 participants in 2 patient groups

with arthrogenic Muscle Inhibition
Experimental group
Treatment:
Diagnostic Test: functional brain MRI
without arthrogenic Muscle Inhibition
Active Comparator group
Treatment:
Diagnostic Test: functional brain MRI

Trial contacts and locations

1

Loading...

Central trial contact

Etienne CAVAIGNAC, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems